Chicago Partners Investment Group LLC Axsome Therapeutics, Inc. Transaction History

Chicago Partners Investment Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$30.7 - $43.36 $204,554 - $288,907	-6,663 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$19.91 - $68.26 $132,660 - $454,816	6,663 New	6,663 $219,000
Q2 2021 Aug 02, 2021	SELL	$50.63 - $73.5 $180,698 - $262,321	-3,569 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$55.91 - $81.44 $47,691 - $69,468	853 Added 31.41%	3,569 $210,000
Q4 2020 Jan 27, 2021	BUY	$66.31 - $86.52 $180,097 - $234,988	2,716 New	2,716 $203,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.73B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Chicago Partners Investment Group LLC, based on Form 13F filings with the SEC.

Stay updated on Chicago Partners Investment Group LLC with notifications on news.